Close Server: KOPWWW05 | Not logged in


Welcome to Health Care POV | sign in | join

BROWSE BY TAGS

ADVANCE Perspective: Respiratory Views

FDA Approves Symbicort For Treatment of Asthma in Pediatric Patients
February 3, 2017 11:42 AM by ADVANCE for Respiratory Care & Sleep Medicine
In major news for pediatric asthma patients, AstraZeneca this week announced that the U.S. Food and Drug Administration (FDA) approved SYMBICORT® (budesonide/formoterol fumarate dihydrate) Inhalation Aerosol 80/4.5 micrograms for the treatment of asthma Read More...
1 comments »     
Medicated Millennials
April 6, 2016 1:13 PM by ADVANCE for Respiratory Care & Sleep Medicine
By Tamer Abouras In spite of the fact that professional writing has increasingly moved to a digital medium, there is nonetheless an almost endless amount of ink (figuratively speaking) spent describing the “millennial” generation. Whether it’s their effect Read More...
0 comments »     
The Inhaler Hacking Arms Race
December 4, 2015 8:02 AM by ADVANCE for Respiratory Care & Sleep Medicine
By Tamer Abouras There are many, many blog entries and articles written daily which begin something like this: “There’s no getting around the fact that we’re currently living in the age of … [insert modern buzzword here].” Probably everyone is guilty Read More...
0 comments »     
CVS Funds Smoking Cessation Program for Veterans, Others
May 28, 2015 9:15 AM by ADVANCE for Respiratory Care & Sleep Medicine
Easter Seals is marking World No Tobacco Day on May 31, by launching a national smoking cessation program to help veterans, people with disabilities and caregivers live healthier, tobacco-free lives. Funding for the new program is supported by a $400,000 Read More...
0 comments »     
Improving Aerosol Therapy for Respiratory Disorders
May 1, 2015 9:15 AM by ADVANCE for Respiratory Care & Sleep Medicine
Premier healthcare innovation marketplace, Edison Nation Medical, and the American Association for Respiratory Care (AARC), have announced a global search to uncover innovations for improving aerosol therapy for patients with respiratory disorders. Inhaled Read More...
0 comments »     
FDA Pulls Unapproved Cold and Allergy Drugs; AAAAI Weighs In
March 3, 2011 11:07 AM by Valerie Newitt
The U.S. Food and Drug Administration announced March 2 that they are requiring the removal of unapproved prescription cold, oral cough and allergy products from the market, ranging from Accuhist DM to Zotex tablets in an A-to-Z banishment of hundreds Read More...
0 comments »     

Search

About this Blog

Keep Me Updated